CELLULAR-DISTRIBUTION OF ANGIOTENSIN-CONVERTING ENZYME AFTER MYOCARDIAL-INFARCTION

被引:144
|
作者
FALKENHAHN, M
FRANKE, F
BOHLE, RM
ZHU, YC
STAUSS, HM
BACHMANN, S
DANILOV, S
UNGER, T
机构
[1] UNIV GIESSEN,DEPT PATHOL,GIESSEN,GERMANY
[2] UNIV HEIDELBERG,DEPT ANAT & CELL BIOL,HEIDELBERG,GERMANY
[3] NATL CARDIOL RES CTR,MOSCOW,RUSSIA
关键词
ANGIOTENSIN-CONVERTING ENZYME; HEART; MYOCARDIAL INFARCTION; ENDOTHELIUM; MACROPHAGES;
D O I
10.1161/01.HYP.25.2.219
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We studied the cellular distribution of angiotensin-converting enzyme (ACE) in the heart related to the cell types involved in left ventricular repair and remodeling before and after myocardial infarction by immunohistochemical techniques using monoclonal and polyclonal antibodies. In noninfarcted myocardium of both human and rat, ACE expression was confined to endothelial cells and subendocardial cell layers of the aortic valve. ACE was prominent in endothelia of small arteries and arterioles, whereas only half the coronary capillaries were immunoreactive and venous vessels were almost completely devoid of the enzyme. In a rat model of myocardial infarction, ACE distribution was determined 1, 3, and 7 days and 2, 3, and 6 weeks after coronary occlusion. Three and 7 days after infarction, endothelial cells of sprouting capillaries and macrophages in the marginal zone of necrosis revealed ACE expression. In both human and rat with the onset of fibrosis, intense staining of the enzyme was found in the marginal zone of the repair tissue. In situ hybridization for collagen type I in the rat revealed that zones with high collagen content had almost no ACE immunoreactivity. Vascular smooth muscle cells and cardiomyocytes revealed no ACE expression throughout the study. We conclude that endothelial cells are the principal source for the expression of ACE after myocardial infarction. The observed induction of ACE with the onset of fibrosis suggests a role of this enzyme that is related to tissue repair and remodeling.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [21] Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction
    Hokimoto, S
    Yasue, H
    Fujimoto, K
    Yamamoto, H
    Nakao, K
    Kaikita, K
    Sakata, R
    Miyamoto, E
    CIRCULATION, 1996, 94 (07) : 1513 - 1518
  • [22] Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction
    Duncan, AM
    Burrell, LM
    Kladis, A
    Campbell, DJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (06) : 746 - 754
  • [23] EFFICACY OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND AT(1) RECEPTOR BLOCKADE ON CARDIAC PUMP PERFORMANCE AFTER MYOCARDIAL-INFARCTION IN RATS
    CAPASSO, JM
    LI, P
    MEGGS, LG
    HERMAN, MV
    ANVERSA, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (04) : 584 - 593
  • [24] Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats
    Taylor, K
    Patten, RD
    Smith, JJ
    Aronovitz, MJ
    Wight, J
    Salomon, RN
    Konstam, MA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (05) : 654 - 660
  • [25] Angiotensin-converting enzyme inhibition in myocardial infarction .1. Clinical data
    Huckell, VF
    Bernstein, V
    Cairns, JA
    Crowell, R
    Dagenais, GR
    Higginson, LA
    Isserow, S
    Laramee, P
    Liu, P
    McCans, JL
    Orchard, RC
    Prewitt, R
    Quinn, BP
    Samson, M
    Turazza, F
    Warnica, JW
    Wielgosz, A
    CANADIAN JOURNAL OF CARDIOLOGY, 1997, 13 (02) : 161 - 169
  • [26] Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction
    Qu, Zhe
    Xu, Hongxin
    Tian, Yihao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 3410 - 3417
  • [27] Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction
    Tokunaga, S
    Tsuji, H
    Nishiue, T
    Yamada, K
    Miyasaka, Y
    Saitou, D
    Iwasaka, T
    ACTA CARDIOLOGICA, 2001, 56 (06) : 351 - 355
  • [28] Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function
    Reikvam, A
    Kvan, E
    Landmark, K
    Aursnes, I
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2003, 37 (03) : 130 - 134
  • [29] Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction
    Konermann, M
    Altmann, C
    Laschewski, F
    Josephs, W
    Odenthal, HJ
    Horstmann, E
    Sanner, B
    CLINICAL CARDIOLOGY, 1998, 21 (04) : 277 - 285
  • [30] UK PROSPECTIVE DIABETES STUDY (UKPDS) .14. ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM WITH MYOCARDIAL-INFARCTION IN NIDDM
    KEAVNEY, BD
    DUDLEY, CRK
    STRATTON, IM
    HOLMAN, RR
    MATTHEWS, DR
    RATCLIFFE, PJ
    TURNER, RC
    DIABETOLOGIA, 1995, 38 (08) : 948 - 952